M A Gulak1,2, C Bornais2, S Shin2, L Murphy2, J Smylie2, J R Pantarotto1,2,3, M Fung-Kee-Fung1,2,4, D E Maziak1,2,5. 1. Faculty of Medicine, University of Ottawa, Ottawa, ON. 2. The Ottawa Hospital Research Institute, The Ottawa Hospital, Ottawa, ON. 3. Division of Radiation Oncology, The Ottawa Hospital, Ottawa, ON. 4. Division of Gynecologic Oncology, The Ottawa Hospital, Ottawa, ON. 5. Division of Thoracic Surgery, The Ottawa Hospital, Ottawa, ON.
Abstract
Background: Patients with lung cancer often experience stressful delays throughout the diagnostic phase of care. To address that situation, our multidisciplinary team created a "Navigation Day," during which patients partake in a single-day visit that comprises nurse-led teaching, social work, smoking cessation counselling, symptom control, and dedicated test slots for integrated positron-emission tomography and computed tomography (pet/ct), pulmonary function tests (pfts), and magnetic resonance imaging (mri) of the brain. We evaluated the effects of that program on wait times and patient satisfaction. Methods: Patients with a suspicion of lung cancer on chest ct imaging referred during 3 time periods were reviewed: 1 year before launch of the Navigation Day, 1 year post-launch, and 2 years post-launch. Patients were further stratified according to concordance of their test date with a Navigation Day date. Mean wait times for pet/ct, pfts, and mri brain were calculated for each group. Patient satisfaction was measured using a standardized provincial survey. The Student t-test and analysis of variance were used to assess for significance. Results: After implementation, mean wait times in the first year improved to 9.2 days from 15.5 days for pet/ct (p < 0.0001), to 9.6 days from 15.7 days for pfts (p < 0.0001), and to 10.2 days from 16.0 days for mri brain (p < 0.0001). Patients who used a dedicated test slot experienced the shortest wait times, at 5.8 days for pet/ct, 5.8 days for pfts, and 6.3 days for mri brain (p < 0.0001). Those improvements were sustained at 2 years post-launch. Patient satisfaction in the categories of assistance, emotional support, and clarity remained high post-launch. Conclusions: Navigation Day significantly improved the timeliness of diagnostic testing services in patients with suspected lung cancer. 2019 Multimed Inc.
Background: Patients with lung cancer often experience stressful delays throughout the diagnostic phase of care. To address that situation, our multidisciplinary team created a "Navigation Day," during which patients partake in a single-day visit that comprises nurse-led teaching, social work, smoking cessation counselling, symptom control, and dedicated test slots for integrated positron-emission tomography and computed tomography (pet/ct), pulmonary function tests (pfts), and magnetic resonance imaging (mri) of the brain. We evaluated the effects of that program on wait times and patient satisfaction. Methods:Patients with a suspicion of lung cancer on chest ct imaging referred during 3 time periods were reviewed: 1 year before launch of the Navigation Day, 1 year post-launch, and 2 years post-launch. Patients were further stratified according to concordance of their test date with a Navigation Day date. Mean wait times for pet/ct, pfts, and mri brain were calculated for each group. Patient satisfaction was measured using a standardized provincial survey. The Student t-test and analysis of variance were used to assess for significance. Results: After implementation, mean wait times in the first year improved to 9.2 days from 15.5 days for pet/ct (p < 0.0001), to 9.6 days from 15.7 days for pfts (p < 0.0001), and to 10.2 days from 16.0 days for mri brain (p < 0.0001). Patients who used a dedicated test slot experienced the shortest wait times, at 5.8 days for pet/ct, 5.8 days for pfts, and 6.3 days for mri brain (p < 0.0001). Those improvements were sustained at 2 years post-launch. Patient satisfaction in the categories of assistance, emotional support, and clarity remained high post-launch. Conclusions: Navigation Day significantly improved the timeliness of diagnostic testing services in patients with suspected lung cancer. 2019 Multimed Inc.
Authors: Dorothy S Lo; Robert A Zeldin; Roland Skrastins; Ian M Fraser; Harold Newman; Alan Monavvari; Yee C Ung; Harry Joseph; Teresa Downton; Larissa Maxwell; Jacinta Meharchand Journal: J Thorac Oncol Date: 2007-11 Impact factor: 15.609
Authors: Jessica L Common; Hensley H Mariathas; Kaylah Parsons; Jonathan D Greenland; Scott Harris; Rick Bhatia; Suzanne C Byrne Journal: Can Assoc Radiol J Date: 2018-06-04 Impact factor: 2.248
Authors: Susan Alsamarai; Xiaopan Yao; Hilary C Cain; Bryan W Chang; Herta H Chao; Donna M Connery; Yanhong Deng; Vijay N Garla; Laura S Hunnibell; Anthony W Kim; J Antonio Obando; Caroline Taylor; George Tellides; Michal G Rose Journal: Clin Lung Cancer Date: 2013-07-01 Impact factor: 4.785
Authors: Pepijn Brocken; Erik H F M van der Heijden; Karen T M Oud; Gerben Bootsma; Harry J M Groen; A Rogier T Donders; P N Richard Dekhuijzen; Judith B Prins Journal: Psychooncology Date: 2014-09-09 Impact factor: 3.894
Authors: Margo M Jacobsen; Sophie C Silverstein; Michael Quinn; Leo B Waterston; Christian A Thomas; James C Benneyan; Paul K J Han Journal: Lung Cancer Date: 2017-08-15 Impact factor: 5.705
Authors: M Fung-Kee-Fung; D E Maziak; J R Pantarotto; J Smylie; L Taylor; T Timlin; T Cacciotti; P J Villeneuve; C Dennie; C Bornais; S Madore; J Aquino; P Wheatley-Price; R S Ozer; D J Stewart Journal: Curr Oncol Date: 2018-02-28 Impact factor: 3.677
Authors: Ellen Moseholm; Susan Rydahl-Hansen; Dorthe Overgaard; Hanne S Wengel; Rikke Frederiksen; Malene Brandt; Bjarne Ø Lindhardt Journal: Health Qual Life Outcomes Date: 2016-05-20 Impact factor: 3.186